TFO
GILD icon

Tarbox Family Office’s Gilead Sciences GILD Stock Holding History

Tarbox Family Office’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$391K Sell
2,808
-372
-12% -$52.1K 0.06% 75
2025
Q4 		$390K Sell
3,180
-98
-3% -$11.9K 0.06% 80
2025
Q3 		$364K Buy
3,278
+2
+0.1% +$227 0.05% 88
2025
Q2 		$363K Buy
3,276
+2
+0.1% +$213 0.05% 86
2025
Q1 		$367K Sell
3,274
-11
-0.3% -$1.14K 0.06% 80
2024
Q4 		$303K Buy
3,285
+11
+0.3% +$990 0.05% 91
2024
Q3 		$274K Sell
3,274
-30
-0.9% -$2.29K 0.05% 100
2024
Q2 		$227K Sell
3,304
-28
-0.8% -$1.87K 0.04% 99
2024
Q1 		$244K Sell
3,332
-18
-0.5% -$1.38K 0.04% 97
2023
Q4 		$271K Buy
3,350
+1
+0% +$78 0.05% 82
2023
Q3 		$251K Sell
3,349
-5
-0.1% -$385 0.05% 88
2023
Q2 		$258K Buy
3,354
+20
+0.6% +$1.59K 0.05% 91
2023
Q1 		$277K Sell
3,334
-3,189
-49% -$264K 0.06% 87
2022
Q4 		$560K Buy
6,523
+35
+0.5% +$2.77K 0.12% 47
2022
Q3 		$401K Hold
6,488
– – 0.1% 59
2022
Q2 		$401K Sell
6,488
-23
-0.4% -$1.42K 0.09% 72
2022
Q1 		$387K Sell
6,511
-255
-4% -$16.3K 0.08% 68
2021
Q4 		$491K Buy
6,766
+30
+0.4% +$2.07K 0.08% 77
2021
Q3 		$471K Buy
6,736
+4
+0.1% +$281 0.09% 78
2021
Q2 		$464K Hold
6,732
– – 0.08% 82
2021
Q1 		$435K Hold
6,732
– – 0.09% 79
2020
Q4 		$392K Sell
6,732
-74
-1% -$4.46K 0.08% 82
2020
Q3 		$430K Sell
6,806
-37
-0.5% -$2.57K 0.1% 70
2020
Q2 		$527K Sell
6,843
-11
-0.2% -$843 0.14% 51
2020
Q1 		$512K Buy
6,854
+262
+4% +$18.1K 0.17% 49
2019
Q4 		$428K Sell
6,592
-18
-0.3% -$1.17K 0.12% 66
2019
Q3 		$419K Buy
6,610
+8
+0.1% +$523 0.13% 51
2019
Q2 		$446K Buy
6,602
+86
+1% +$5.66K 0.14% 51
2019
Q1 		$424K Buy
6,516
+86
+1% +$5.72K 0.16% 49
2018
Q4 		$402K Sell
6,430
-139
-2% -$9.71K 0.17% 47
2018
Q3 		$507K Sell
6,569
-11
-0.2% -$831 0.18% 40
2018
Q2 		$466K Buy
6,580
+1
+0% +$71 0.18% 41
2018
Q1 		$496K Buy
6,579
+25
+0.4% +$1.99K 0.19% 39
2017
Q4 		$470K Sell
6,554
-5
-0.1% -$380 0.19% 43
2017
Q3 		$531K Buy
6,559
+74
+1% +$5.66K 0.23% 34
2017
Q2 		$459K Sell
6,485
-3
-0% -$200 0.23% 33
2017
Q1 		$441K Buy
6,488
+1
+0% +$70 0.23% 33
2016
Q4 		$465K Sell
6,487
-35
-0.5% -$2.6K 0.27% 27
2016
Q3 		$516K Buy
6,522
+27
+0.4% +$2.19K 0.33% 24
2016
Q2 		$542K Sell
6,495
-39
-0.6% -$3.46K 0.39% 22
2016
Q1 		$600K Buy
6,534
+1
+0% +$90 0.45% 22
2015
Q4 		$661K Buy
6,533
+15
+0.2% +$1.56K 0.54% 21
2015
Q3 		$640K Sell
6,518
-8
-0.1% -$889 0.59% 19
2015
Q2 		$764K Hold
6,526
– – 0.66% 19
2015
Q1 		$640K Sell
6,526
-1
-0% -$102 0.56% 24
2014
Q4 		$615K Sell
6,527
-43
-0.7% -$4.45K 0.57% 23
2014
Q3 		$699K Buy
6,570
+55
+0.8% +$5.39K 0.63% 21
2014
Q2 		$540K Buy
6,515
+2,000
+44% +$156K 0.48% 28
2014
Q1 		$333K Buy
4,515
+8
+0.2% +$627 0.3% 41
2013
Q4 		$338K Buy
+4,507
New +$314K 0.28% 44

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tarbox Family Office's GILD Position: Q1 2026 in Review

Tarbox Family Office reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $52.1K and leaving 2,808 shares worth $391K. The position accounts for 0.06% of the portfolio, ranked #75.

Tarbox Family Office first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $764K in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Tarbox Family Office held 2,808 shares of Gilead Sciences worth $391K as of Q1 2026.
  • Tarbox Family Office sold 372 Gilead Sciences shares in Q1 2026, an estimated $52.1K.
  • Gilead Sciences made up 0.06% of Tarbox Family Office's portfolio in Q1 2026, its #75 holding.
  • Tarbox Family Office first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Tarbox Family Office's Gilead Sciences position peaked at $764K in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Tarbox Family Office's 13F filing for Q1 2026, filed 24 Apr 2026.